A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease ; volume:9 ; number:1 ; day:8 ; month:7 ; year:2019 ; pages:1-14 ; date:12.2019
Scientific reports ; 9, Heft 1 (8.7.2019), 1-14, 12.2019
- Creator
-
Gibbs, Ebrima
Silverman, Judith M.
Zhao, Beibei
Peng, Xubiao
Wang, Jing
Wellington, Cheryl L.
Mackenzie, Ian R.
Plotkin, Steven S.
Kaplan, Johanne M.
Cashman, Neil R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-46306-5
- URN
-
urn:nbn:de:101:1-2019103106020950556615
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gibbs, Ebrima
- Silverman, Judith M.
- Zhao, Beibei
- Peng, Xubiao
- Wang, Jing
- Wellington, Cheryl L.
- Mackenzie, Ian R.
- Plotkin, Steven S.
- Kaplan, Johanne M.
- Cashman, Neil R.
- SpringerLink (Online service)
Other Objects (12)
Specific detection of tau seeding activity in Alzheimer’s disease using rationally designed biosensor cells
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Rationally designed DNA origami hosts for protein guests
Rationally Designed Peptoid Inhibitors of Amyloid‐β Oligomerization
Characterization of high-density prion protein oligomers in rapid progressive and sporadic Alzheimer’s disease
A single-domain antibody detects and neutralises toxic Aβ42 oligomers in the Alzheimer’s disease CSF
Specific detection of tau seeding activity in Alzheimer’s disease using rationally designed biosensor cells
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Rationally designed DNA origami hosts for protein guests
Rationally Designed Peptoid Inhibitors of Amyloid‐β Oligomerization
Characterization of high-density prion protein oligomers in rapid progressive and sporadic Alzheimer’s disease
A single-domain antibody detects and neutralises toxic Aβ42 oligomers in the Alzheimer’s disease CSF
Specific detection of tau seeding activity in Alzheimer’s disease using rationally designed biosensor cells
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Rationally designed DNA origami hosts for protein guests
Rationally Designed Peptoid Inhibitors of Amyloid‐β Oligomerization
Characterization of high-density prion protein oligomers in rapid progressive and sporadic Alzheimer’s disease